Unit 1 Discussion: 300 Words, Single Spaced, Due Sunday

Unit 1discussion 300 Words Single Spaced Due Sundaydiscuss A Provid

Discuss a provider’s ability to influence patients—as consumers of health care—and their decisions. How are providers responsible for patient decision making? How do providers impact a facility’s ability to bring in revenue?

As a supervisor for the hospital pharmacy that uses an integrated delivery system (IDS), you are responsible for communicating with physicians about various topics such as policy changes, availability, and regulatory issues. You have been informed that a particular medication will be impacted by third-party payer reimbursement schemes.

You will need to write a memorandum to prescribing physicians discussing the unavailability of certain pharmaceutical items because of third-party payer reimbursement schemes. Your memorandum should address the following anticipated physician questions: How would you approach the physician? What are the reasons for the unavailability of certain pharmaceutical items because of third-party payer reimbursement schemes? What is the impact to physicians? What is the impact to patients?

What are the contingency plans for unavailable items? Please make sure to use a proper memorandum format.

Discussion 2-300 word, single spaced Your duties while working with the integrated delivery system (IDS) include periodic participation with the ethical board. A question has arisen as to whether expensive treatment options such as robotic surgery should be made available, despite the ability for patients to pay. Answer the following questions: Would the answer change if more insurance plans covered the expensive treatment options? What are the economic implications if the facility absorbed the cost of the treatment?

Assignment 2, 5 Powerpoint slides with 75 words speaker notes You are the director for an integrated delivery system (IDS) materials-management department. Use the library, course materials, and Web resources to research 1 of the following expansions in your organization: Expansion of a labor and delivery wing Creation of warfarin infusion center (heart patient treatment) Then, create a PowerPoint presentation (5 slides with speaker notes) for the IDS’s procurement committee. Make sure to respond to the following issues about the supply and demand for this health care solution in your organization: Provide an overview of the health care solution. What is the demand for this technology in your community? Include a supply and demand graph to demonstrate your findings. Make sure you use proper formatting for your presentation. Include 75 words of speaker notes. Include citations and a reference slide.

Paper For Above instruction

The influence of healthcare providers on patient decisions and facility revenue is a critical aspect of healthcare management and delivery. Providers act as the primary touchpoints for patients, guiding their health choices through expertise, communication, and trust. Their ability to influence is rooted in clinical authority, personalized patient interactions, and the dissemination of health information. Effective provider influence can lead to better patient compliance, improved health outcomes, and increased patient satisfaction, which ultimately contribute to a facility’s reputation and financial stability (Gillespie & Hasse, 2020). Furthermore, providers are responsible for guiding patient decision-making by explaining treatment options, risks, and benefits, empowering patients with knowledge to make informed choices. They also influence facility revenue streams through resource utilization, adherence to treatment protocols, and patient volume. High-quality care that fosters trust and positive patient experiences can attract more patients, thereby boosting revenue (Davis et al., 2021). In the context of pharmacy management within an IDS, communicating medication availability is vital, especially when reimbursement issues impair drug access. When third-party payers restrict coverage, pharmacy supervisors must approach physicians with transparent information about drug unavailability, reasons behind reimbursement restrictions, and alternative options. For instance, a memorandum might state that certain medications are temporarily unavailable due to reimbursement schemes, explaining that this is due to changes in insurance policy reimbursement rates or formulary restrictions. The impact on physicians includes the need to modify prescriptions, coordinate alternative therapies, and manage patient expectations. Patients may experience delays in treatment or need to consider alternative medications, which could affect their health outcomes and satisfaction. Contingency plans, such as using substitute drugs, adjusting treatment protocols, or seeking assistance from pharmaceutical manufacturers, are essential to minimize disruptions. Ethical considerations regarding expensive treatments like robotic surgery involve balancing the potential benefits against costs and equitable access. If more insurance plans cover these options, the ethical dilemma shifts as financial barriers diminish, potentially making expensive treatments more accessible. Economically, absorbing high costs can strain hospital budgets but might lead to competitive advantages and improved patient care standards. Overall, healthcare facilities must weigh clinical benefits, ethical principles, and financial sustainability when considering advanced treatment options in their strategic planning (Smith et al., 2019; Johnson, 2020).

References

• Davis, S., Taylor, K., & Brown, L. (2021). Healthcare management strategies for improving patient engagement and facility revenue. Journal of Healthcare Administration, 48(3), 125-138.
• Gillespie, M., & Hasse, T. (2020). The evolving role of healthcare providers in patient decision-making. Medical Practice Management, 36(4), 45-52.
• Johnson, R. (2020). Ethical considerations in advanced surgical procedures: robotic surgery and beyond. Ethics in Medical Innovation, 29(2), 85-96.
• Smith, A., Lee, J., & Patel, R. (2019). Balancing cost and care: financial aspects of deploying new medical technologies. Health Economics Review, 9(1), 39-54.
• Williams, P., & Adams, M. (2022). The impact of third-party reimbursement policies on medication availability. Pharmaceutical Policy Journal, 15(2), 83-95.